2024 Annual Meeting | C56 - Skills Workshop: Interventional Headache Management: Botulinum Toxin, Nerve Blocks, and Trigger Point Injections

Date Sunday 04/14/24

Time 01:00 PM - 05:30 PM MDT Add To Calendar

Location Hyatt Regency | Mineral Hall A

Session Format This program will be presented in-person only

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Skills Workshop

Director(s) Hope O'Brien, MD, MBA, FAAN

Topic(s) Headache

Learning Objectives Participants should become familiar with the indications of interventional treatment of headache which include invasive and non-invasive options. Invasive techniques include peripheral cranial nerve blocks, trigger point injections, and onabotulinumtoxinA. Non-invasive treatment include the use of neurmodulation devices. Participants will gain hands-on experience with these techniques during break-out sessions.

This program is supported in part by an educational grant, specifically monetary and in-kind support of medical equipment and supplies, from AbbVie Inc.

CME Available 4.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Advanced Practice Provider

Teaching Styles Case-based, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:15 PM MDT	Introduction	Introduction to Interventional Headache Management Hope O'Brien, MD, MBA, FAAN
01:15 PM - 02:00 PM MDT	Speaker	OnabotulinumtoxinA in the Treatment of Chronic Migraine Andrew M. Blumenfeld, MD, FAAN
02:00 PM - 02:45 PM MDT	Speaker	Cranial Nerve Blocks and Trigger Point Injections to Treat Head Pain Lauren R. Natbony, MD
02:45 PM - 03:30 PM MDT	Speaker	The Use of Neuromodulation and the Role of Surgical Intervention in Headache Management Michael J. Marmura, MD, FAAN
03:30 PM - 03:50 PM MDT	Q&A	Speaker Panel Discussion Lauren R. Natbony, MD, Andrew M. Blumenfeld, MD, FAAN, Michael J. Marmura, MD, FAAN, Rashmi B. Halker Singh, MD, FAAN
03:50 PM - 04:00 PM MDT	Break	Break and Transition to Stations
04:00 PM - 05:30 PM MDT	Discussion	Breakout Stations Lauren R. Natbony, MD, Andrew M. Blumenfeld, MD, FAAN, Michael J. Marmura, MD, FAAN, Rashmi B. Halker Singh, MD, FAAN

Faculty Disclosures
Hope O'Brien, MD, MBA, FAAN	The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GatherED . The institution of Dr. O'Brien has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. An immediate family member of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Astra Zenica. The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. O'Brien has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ms. Medicine. The institution of Dr. O'Brien has received research support from Abbvie. The institution of Dr. O'Brien has received research support from Eli Lilly. Dr. O'Brien has received publishing royalties from a publication relating to health care. Dr. O'Brien has a non-compensated relationship as a Accreditation Council Member with UCNS that is relevant to AAN interests or activities.
Lauren R. Natbony, MD	Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharmaceuticals. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eNeura. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma. Dr. Natbony has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel Pharmaceuticals . Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Andrew M. Blumenfeld, MD, FAAN	Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck.
Michael J. Marmura, MD, FAAN	Dr. Marmura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Marmura has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Marmura has stock in Curelator. The institution of Dr. Marmura has received research support from Teva. The institution of Dr. Marmura has received research support from AbbVie. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care.
Rashmi B. Halker Singh, MD, FAAN	Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Halker Singh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology & Neuroscience Reports. Dr. Halker Singh has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache Journal. Dr. Halker Singh has received publishing royalties from a publication relating to health care. Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Pri-med. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Medscape.